Customer Letters

Please note, the following Customer Letters, in electronic format, do not replace the print version that you receive from your local Canadian Blood Services site. The print version must be retained as your file copy.

* The contents of the customer letters available on this site are current as of their dates of publication. If required, please contact the Canadian Blood Services staff member identified within the letters or contact your local Hospital Liaison Specialist to determine if the letter is still current.

---

2013 | 2012 | 2011 | 2010 |2009 | 2008 |2007 |2006 | 2005 | 2004 | 2003

Contact Lists Referenced in Customer Letters	Effective Date
Medical Directors	July 2012
Hospital Liaisons	2008-02-01

Letter #	Date	Title
2013-19	2013-06-13	IMPORTANT INFORMATION Requisition For Blood Group Genotyping (Patient) NIRL/ Requisition For Antibody Investigation NIRL Requisition for Blood Group Genotyping (Patient) National Immunohematology Reference Laboratory (NIRL) REQUISITION FOR ANTIBODY INVESTIGATION National Immunohematology Reference Laboratory (NIRL)
2013-18	2013-05-27	Information Only New Contact Information for all Atlantic Medical Offices at Canadian Blood Services
2013-17	2013-05-15	Information Only Change to Canadian Blood Services Tamper Indicator Device - All Hospitals EXCEPT BC & Yukon Hospitals
2013-16	2013-05-08	Information Only Changes to Plasma Protein Products Distributed by Canadian Blood Services New pre-filled diluent Syringe with Kogenate® FS Privigen® 2.5g vial size available for distribution in Canada What's New With BeneFIX®? New Indication. New Vial Size. Addition of Ancillaries to Berinert® Package
2013-17	2013-05-01	Information Only Canadian Blood Services Logistics Delivery Pilot - Dartmouth Production and Distribution Site
2013-15 Update	2013-05-16	Information Only Circular of Information – Release of the Red Blood Cells LR SAGM Added Updates to the Frozen & Deglycerolized Red Blood Cell Processes at Canadian Blood Services, April 2013 Version
2013-15	2013-05-02	Information Only Circular of Information – Release of the Red Blood Cells LR SAGM Added Updates to the Frozen & Deglycerolized Red Blood Cell Processes at Canadian Blood Services April 2013 Version
2013-14	2013-05-01	Information Only Canadian Blood Services Logistics Delivery Pilot - Dartmouth Production and Distribution Site
2013-13	2013-04-24	Information Only Washed Red Blood Cells With Extended Expiry ISBT 128 Sample Labels and Product Codes Attachments Product Codes and Label Text WASH RBC LR SAGM 2-1 WASH RBC LR SAGM 2-2 WASH RBC LR SAGM 2-3 WASH RBC LR SAGM 2-4
2013-12	2013-04-22	Information Only Launch of octagam® 10% Immune Globulin Intravenous (Human) Octagam Canadian Blood Services HCP introduction letter Canadian Blood Services Octagam product profile letter
2013-11	2013-04-11	Information Only RiaSTAP™ and Haemocomplettan® P Distribution
2013-10 Update II	2013-06-06	Information Only Phenotype Tag L040995
2013-10 Update	2013-05-09	Information Only Phenotype Tag L040995
2013-10	2013-04-08	Information Only Improvements to Donor Red Cell Phenotype Tags Phenotype Information Provided to Hospitals by Canadian Blood Services Red Blood Cell Label and Tags
2013-09	2013-03-18	Information Only 2012 Hospital Satisfaction Survey Summary
2013-08	2013-03-11	Information Only Important Information Regarding Availability of Immune Globulin Products and Prothrombin Complex Concentrates for 2013-2014
2013-07	2013-02-13	Information Only Product Labeling Change for Deglycerolized Red Blood Cells including Circular of Information Change and Labeling Change for Frozen Red Blood Cells Attachment #1 Attachment #2
2013-06	2013-02-12	Information Only Tretten® Distribution INTRODUCING TRETTEN®: A RECOMBINANT COAGULATION FXIII-A21* Tretten® (catridecacog) – A recombinant factor XIII A-subunit1
2013-05	2013-02-11	Action Required Canadian Blood Services’ Saint John Site Move to Dartmouth Facility
2013-04	2013-01-22	Information Only RiaSTAP™ Distribution RiaSTAPTM (Fibrinogen Concentrate (Human), FCH)
2013-03	2013-02-07	Information Only Emergency Framework - Synopsis for Triage Teams
2013-02	2013-01-21	Information Only Recombinant Factor VIII Transition
2013-01	2013-01-07	Action Required Canadian Blood Services’ Halifax Site Move to Dartmouth Facility

/\ Top